approval
saveHUMIRA (ADALIMUMAB) — FDA approval
community read0 votes
Sponsor: ABBVIE INC. Form: VIAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalHUMIRA (ADALIMUMAB) — FDA approvalDec 23, 2025 · 285d ago
- approvalHUMIRA (ADALIMUMAB) — FDA approvalJul 16, 2025 · 445d ago
- approvalHUMIRA (ADALIMUMAB) — FDA approvalNov 3, 2023 · 1066d ago
- approvalHUMIRA (ADALIMUMAB) — FDA approvalFeb 24, 2021 · 2048d ago
- approvalHUMIRA (ADALIMUMAB) — FDA approvalDec 16, 2020 · 2118d ago
- approvalHUMIRA (ADALIMUMAB) — FDA approvalDec 16, 2020 · 2118d ago
- approvalHUMIRA (ADALIMUMAB) — FDA approvalMar 11, 2020 · 2398d ago
- approvalHUMIRA (ADALIMUMAB) — FDA approvalJan 11, 2019 · 2823d ago
same company · ±60 days · 6
- approvaladalimumab: HUMIRA (ADALIMUMAB) — FDA approvalMay 30, 2014
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalJun 9, 2014
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalJun 9, 2014
- approvaldivalproex sodium DR: DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalJun 9, 2014
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalJun 19, 2014
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalJun 19, 2014
🐶 often sniffed alongside
top 8- tagApproval432 co-mentions · 155 sources
- drugHUMIRA359 co-mentions · 156 sources
- drugAMJEVITA168 co-mentions · 94 sources
- drugABRILADA156 co-mentions · 88 sources
- drugYUSIMRY152 co-mentions · 86 sources
- company$ABBVAbbVie Inc.122 co-mentions · 61 sources
- drugYUFLYMA28 co-mentions · 14 sources
- drugHADLIMA26 co-mentions · 13 sources
comments(0)
5-min edit window · permanent after that